Outlook Therapeutics, Inc. (OTLK) vs Voyager Therapeutics, Inc. (VYGR)
- Outlook Therapeutics, Inc. OTLK 0.49 −2.00%
- Voyager Therapeutics, Inc. VYGR 1.90 −7.77%
Outlook Therapeutics, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. Outlook Therapeutics, Inc. and Voyager Therapeutics, Inc. are of similar size ($126.9M and $121.7M). Voyager Therapeutics, Inc. grew revenue faster over the last twelve months: −19.1% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −312.6%) and the higher return on invested capital (0.00% vs −192.6%). Across the 16 metrics below, Outlook Therapeutics, Inc. leads on 12 and Voyager Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | OTLK | VYGR | Biotechnology median |
|---|---|---|---|
| Gross margin | 195.62% | 100.00% | 65.16% |
| Operating margin | 4,781.76% | (340.08%) | 0.00% |
| Net margin | 5,253.40% | (312.63%) | 0.00% |
| Free cash flow margin | 4,826.38% | (352.36%) | 0.00% |
| Return on equity | 256.92% | (54.09%) | (56.36%) |
| Return on assets | (251.66%) | (41.45%) | (48.04%) |
| Return on invested capital | 0.00% | (192.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack